Amphastar Pharmaceuticals
AMPH
AMPH
116 hedge funds and large institutions have $296M invested in Amphastar Pharmaceuticals in 2017 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 49 increasing their positions, 40 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
31% less call options, than puts
Call options by funds: $286K | Put options by funds: $416K
57% less first-time investments, than exits
New positions opened: 12 | Existing positions closed: 28
Holders
116
Holding in Top 10
–
Calls
$286K
Puts
$416K
Top Buyers
| 1 | +$80M | |
| 2 | +$9.06M | |
| 3 | +$4.89M | |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
+$3.77M |
| 5 |
State Street
Boston,
Massachusetts
|
+$1.54M |
Top Sellers
| 1 | -$14.7M | |
| 2 | -$13.5M | |
| 3 | -$4.34M | |
| 4 |
Prudential Financial
Newark,
New Jersey
|
-$3.79M |
| 5 |
EI
EAM Investors
Solana Beach,
California
|
-$3.19M |